Share on StockTwits

SurModics (NASDAQ:SRDX) hit a new 52-week low during trading on Friday , Analyst Ratings Net reports. The company traded as low as $19.50 and last traded at $19.65, with a volume of 12,027 shares traded. The stock had previously closed at $19.75.

A number of analysts have recently weighed in on SRDX shares. Analysts at Sidoti initiated coverage on shares of SurModics in a research note on Thursday, July 10th. They set a “neutral” rating on the stock. Analysts at Zacks downgraded shares of SurModics from a “neutral” rating to an “underperform” rating in a research note on Monday, May 26th. They now have a $18.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $27.25.

The stock has a 50-day moving average of $20.81 and a 200-day moving average of $22.56. The company has a market cap of $265.9 million and a P/E ratio of 21.85.

SurModics (NASDAQ:SRDX) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.22 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.20 by $0.02. The company had revenue of $13.60 million for the quarter, compared to the consensus estimate of $14.40 million. During the same quarter last year, the company posted $0.20 earnings per share. SurModics’s revenue was down .7% compared to the same quarter last year. On average, analysts predict that SurModics will post $0.91 earnings per share for the current fiscal year.

SurModics, Inc (NASDAQ:SRDX) is a provider of drug delivery and surface modification technologies to the healthcare industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.